M. Cazzola (Rome, Italy), J. Lotvall (Gotheburg, Sweden)
Dose-related efficacy of vilanterol trifenatate (VI), a long-acting beta2 agonist (LABA) with inherent 24-hour activity, in patients with persistent asthma
J. Lötvall, E. D. Bateman, E. R. Bleecker, W. Busse, A. Woodcock, R. Follows, J. Lim, S. Stone, L. Jacques, B. Haumann (Gothenberg, Sweden; Cape Town, South Africa; Winston-Salem, Madison, United States Of America; Manchester, London, United Kingdom)
|  |
Indacaterol provides effective bronchodilation in patients with COPD regardless of concomitant ICS use
M. Decramer, J. Donohue, R. Owen, C. Lassen, B. Kramer (Belgium; North Carolina, East Hanover, United States Of America; West Sussex, United Kingdom)
|  |
Safety and efficacy of fluticasone furoate/vilanterol trifenatate (FFVI) in COPD patients
J. Lötvall, P. Bakke, L. Bjermer, S. Steinshamn, C. Crim, L. Sanford, C. Scott-Wilson, B. Haumann (Gothenberg, Lund, Sweden; Bergen, Trondheim, Norway; RTP, United States Of America; London, United Kingdom)
| |
Four weeks once daily treatment with tiotropium+olodaterol (BI 1744) fixed dose combination compared with tiotropium in COPD patients
F. Maltais, E. Beck, D. Webster, M. R. Maleki-Yazdi, J. V. Seibt, A. Arnoux, A. Hamilton (Toronto, Burlington, Canada; Rüdersdorf, Germany; Killeen, United States Of America; Reims, France)
| |
Aclidinium bromide improves exercise endurance and decreases exertional dyspnoea in patients with COPD
R. Casaburi, F. Maltais, B. Celli, J. Porszasz, E. Garcia Gil, C. Caracta (Torrance, Boston, Jersey City, United States Of America; , Canada; Barcelona, Spain)
|  |
PF-3429281 – A novel inhaled dual antimuscarinic/β2 adrenoceptor agonist in the anaesthetised dog model of bronchoconstriction
K. Wright, N. Clarke, M. Yeadon, C. Perros-Huguet (Sandwich, United Kingdom)
| |
Tiotropium inhibits pulmonary inflammation in a subchronic cigarette smoke mouse model of COPD
L. Wollin, M. Pieper (Biberach, Germany)
| |
Effects of cardioselective β-blockers on dynamic hyperinflation in moderate-to-severe COPD
V. Mainguy, D. Girard, D. Saey, J. Milot, F. Maltais, S. Provencher (Quebec, Canada)
| |